Analyzing Risk Factors for Treatment Failure in Fracture-related Infection

Overview

Journal Arch Orthop Trauma Surg

Specialties Emergency Medicine
General Surgery
Orthopedics

Date 2022 Jan 19

PMID 35043253

Authors

Taylor M Yong

Forrest A Rackard

Lauren K Dutton

Michael B Sparks

Mitchel B Harris

Ida L Gitajn

Affiliations

Soon will be listed here.

Abstract

Introduction: Fracture-related infection (FRI) represents a challenging clinical scenario. Limited evidence exists regarding treatment failure after initial management of FRI. The objective of our investigation was to determine incidence and risk factors for treatment failure in FRI.

Materials And Methods: We conducted a retrospective review of patients treated for FRI between 2011 and 2015 at three level 1 trauma centers. One hundred and thirty-four patients treated for FRI were identified. Demographic and clinical variables were extracted from the medical record. Treatment failure was defined as the need for repeat debridement or surgical revision seven or more days after the presumed final procedure for infection treatment. Univariate comparisons were conducted between patients who experienced treatment failure and those who did not. Multivariable logistic regression was conducted to identify independent associations with treatment failure.

Results: Of the 134 FRI patients, 51 (38.1%) experienced treatment failure. Patients who failed were more likely to have had an open injury (31% versus 17%; p = 0.05), to have undergone implant removal (p = 0.03), and additional index I&D procedures (3.3 versus 1.6; p < 0.001). Most culture results identified a single organism (62%), while 15% were culture negative. Treatment failure was more common in culture-negative infections (p = 0.08). Methicillin-resistant Staphylococcus aureus (MRSA) was the most common organism associated with treatment failure (29%; p = 0.08). Multivariate regression demonstrated a statistically significant association between treatment failure and two or more irrigation and debridement (I&D) procedures (OR 13.22, 95% CI 4.77-36.62, p < 0.001) and culture-negative infection (OR 4.74, 95% CI 1.26-17.83, p = 0.02).

Conclusions: The rate of treatment failure following FRI continues to be high. Important risk factors associated with treatment failure include open fracture, implant removal, and multiple I&D procedures. While MRSA remains common, culture-negative infection represents a novel risk factor for failure, suggesting aggressive treatment of clinically diagnosed cases remains critical even without positive culture data.

Level Of Evidence: Retrospective cohort study; Level III.

Citing Articles

Surgical and microbiological characteristics that influence the probability of reoperation to promote bone healing after fracture-related infection diagnosis.

Alcaide D, Blackwood N, Yeager M, Rutz R, Benson E, Carter K Eur J Orthop Surg Traumatol. 2025; 35(1):74.

PMID: 39994017 DOI: 10.1007/s00590-025-04202-x.

Distally based sural flaps for soft tissue defects following traumatic osteomyelitis of lower leg and foot.

Luo S, Jiang Y, Dong Z, Peng X, Shi S, Luo Z Sci Rep. 2024; 14(1):23214.

PMID: 39369071 PMC: 11455833. DOI: 10.1038/s41598-024-73492-8.

Multisite Study of the Management of Musculoskeletal Infection After Trauma: The MMUSKIT Study.

Seidelman J, Ritter A, Poehlein E, Green C, Briggs D, Chari T Open Forum Infect Dis. 2024; 11(6):ofae262.

PMID: 38854390 PMC: 11161894. DOI: 10.1093/ofid/ofae262.

Time to Positivity in Blood Culture Bottles Inoculated with Sonication Fluid from Fracture-Related Infections.

Henssler L, Schellenberger L, Baertl S, Klute L, Heyd R, Kerschbaum M Microorganisms. 2024; 12(5).

PMID: 38792692 PMC: 11123396. DOI: 10.3390/microorganisms12050862.

Devascularized Bone Surface Culture: A Novel Strategy for Identifying Osteomyelitis-Related Pathogens.

Chen P, Lin Q, Huang M, Zhang X, Hu Y, Chen J J Pers Med. 2022; 12(12).

PMID: 36556270 PMC: 9781165. DOI: 10.3390/jpm12122050.

References

Metsemakers W, Kuehl R, Moriarty T, Richards R, Verhofstad M, Borens O . Infection after fracture fixation: Current surgical and microbiological concepts. Injury. 2016; 49(3):511-522. DOI: 10.1016/j.injury.2016.09.019. View

Whitehouse J, Friedman N, Kirkland K, Richardson W, Sexton D . The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002; 23(4):183-9. DOI: 10.1086/502033. View

Shah R, Plummer D, Moric M, Sporer S, Levine B, Della Valle C . Diagnosing Infection in the Setting of Periprosthetic Fractures. J Arthroplasty. 2016; 31(9 Suppl):140-3. DOI: 10.1016/j.arth.2015.08.045. View

Birt M, Anderson D, Toby E, Wang J . Osteomyelitis: Recent advances in pathophysiology and therapeutic strategies. J Orthop. 2016; 14(1):45-52. PMC: 5090239. DOI: 10.1016/j.jor.2016.10.004. View

Darouiche R . Treatment of infections associated with surgical implants. N Engl J Med. 2004; 350(14):1422-9. DOI: 10.1056/NEJMra035415. View

Jakobsen T, Eickhardt S, Gheorghe A, Stenqvist C, Sonderholm M, Stavnsberg C . Implants induce a new niche for microbiomes. APMIS. 2018; 126(8):685-692. DOI: 10.1111/apm.12862. View

Zimmerli W . Clinical presentation and treatment of orthopaedic implant-associated infection. J Intern Med. 2014; 276(2):111-9. DOI: 10.1111/joim.12233. View

Metsemakers W, Morgenstern M, Senneville E, Borens O, Govaert G, Onsea J . General treatment principles for fracture-related infection: recommendations from an international expert group. Arch Orthop Trauma Surg. 2019; 140(8):1013-1027. PMC: 7351827. DOI: 10.1007/s00402-019-03287-4. View

Tintle S, Forsberg J, Potter B, Islinger R, Andersen R . Prosthesis retention, serial debridement, and antibiotic bead use for the treatment of infection following total joint arthroplasty. Orthopedics. 2009; 32(2):87. View

10.

Moojen D, Zwiers J, Scholtes V, Verheyen C, Poolman R . Similar success rates for single and multiple debridement surgery for acute hip arthroplasty infection. Acta Orthop. 2014; 85(4):383-8. PMC: 4105769. DOI: 10.3109/17453674.2014.927729. View

11.

Greene L . Guide to the elimination of orthopedic surgery surgical site infections: an executive summary of the Association for Professionals in Infection Control and Epidemiology elimination guide. Am J Infect Control. 2011; 40(4):384-6. DOI: 10.1016/j.ajic.2011.05.011. View

12.

Bilgili F, Balci H, Karaytug K, Sariyilmaz K, Atalar A, Bozdag E . Can Normal Fracture Healing Be Achieved When the Implant Is Retained on the Basis of Infection? An Experimental Animal Model. Clin Orthop Relat Res. 2015; 473(10):3190-6. PMC: 4562922. DOI: 10.1007/s11999-015-4331-9. View

13.

Foster A, Moriarty T, Zalavras C, Morgenstern M, Jaiprakash A, Crawford R . The influence of biomechanical stability on bone healing and fracture-related infection: the legacy of Stephan Perren. Injury. 2020; 52(1):43-52. DOI: 10.1016/j.injury.2020.06.044. View

14.

Tornero E, Morata L, Martinez-Pastor J, Bori G, Climent C, Garcia-Velez D . KLIC-score for predicting early failure in prosthetic joint infections treated with debridement, implant retention and antibiotics. Clin Microbiol Infect. 2015; 21(8):786.e9-786.e17. DOI: 10.1016/j.cmi.2015.04.012. View

15.

Kurtz S, Lau E, Son M, Chang E, Zimmerli W, Parvizi J . Are We Winning or Losing the Battle With Periprosthetic Joint Infection: Trends in Periprosthetic Joint Infection and Mortality Risk for the Medicare Population. J Arthroplasty. 2018; 33(10):3238-3245. DOI: 10.1016/j.arth.2018.05.042. View

16.

Kurtz S, Lau E, Watson H, Schmier J, Parvizi J . Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012; 27(8 Suppl):61-5.e1. DOI: 10.1016/j.arth.2012.02.022. View

17.

Metsemakers W, Morgenstern M, McNally M, Moriarty T, McFadyen I, Scarborough M . Fracture-related infection: A consensus on definition from an international expert group. Injury. 2017; 49(3):505-510. DOI: 10.1016/j.injury.2017.08.040. View

18.

Hellebrekers P, Leenen L, Hoekstra M, Hietbrink F . Effect of a standardized treatment regime for infection after osteosynthesis. J Orthop Surg Res. 2017; 12(1):41. PMC: 5345171. DOI: 10.1186/s13018-017-0535-x. View

19.

Hellebrekers P, Verhofstad M, Leenen L, Varol H, Van Lieshout E, Hietbrink F . The effect of early broad-spectrum versus delayed narrow-spectrum antibiotic therapy on the primary cure rate of acute infection after osteosynthesis. Eur J Trauma Emerg Surg. 2019; 46(6):1341-1350. PMC: 7691296. DOI: 10.1007/s00068-019-01182-6. View

20.

Rightmire E, Zurakowski D, Vrahas M . Acute infections after fracture repair: management with hardware in place. Clin Orthop Relat Res. 2008; 466(2):466-72. PMC: 2505119. DOI: 10.1007/s11999-007-0053-y. View